drugset / Trial / NCT05505214

Topical Steroids & Bacterial Decolonization for Radiation Dermatitis

NCT05505214

Phase 2 Withdrawn Montefiore Medical Center
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine whether bacterial decolonization of the nares and skin, topical steroid therapy, or a combination of the two regimens prior to treatment with radiotherapy (RT) for breast and head and neck cancer patients can prevent grade 2 or higher grade radiation dermatitis (RD) graded via the Common Terminology Criteria for Adverse Events (CTCAE) scale and improve quality of life.

Timeline

Start
2023-09-01
Primary completion
2025-09-01
Completion
2025-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine Small molecule Topical
Subject Mometasone furoate Other / unclassified 0.1 % Topical
Subject Mupirocin Small molecule 2 % Intranasal

Indications